Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	5,075	3,739	2,047	1,254	1,132	2,590
Market Cap Growth	160.68%	82.62%	63.27%	10.73%	-56.28%	61.95%
Enterprise Value	4,748	3,457	1,798	1,090	1,008	2,573
Last Close Price	253.25	189.07	107.15	71.42	66.80	154.46
PE Ratio	33.77	30.84	-	24.29	-	46.66
Forward PE	47.81	35.20	53.58	35.07	-	-
PEG Ratio	2.65	2.42	3.57	2.34	-	-
PS Ratio	18.49	13.95	12.25	9.55	5.77	10.72
PB Ratio	5.09	3.68	2.47	1.79	1.90	3.15
P/TBV Ratio	7.61	5.56	4.27	4.26	7.54	7.86
P/FCF Ratio	41.25	76.44	21.50	27.22	9.44	36.98
P/OCF Ratio	41.10	75.74	21.10	25.29	8.21	32.87
EV/Sales Ratio	17.30	12.89	10.76	8.30	5.14	10.65
EV/EBITDA Ratio	35.31	46.23	142.34	23.51	18.48	16.61
EV/EBIT Ratio	46.90	84.30	-	110.96	331.97	24.78
EV/FCF Ratio	38.59	70.68	18.88	23.66	8.41	36.74
Debt / Equity Ratio	0.45	0.44	0.01	0.01	0.02	0.39
Debt / EBITDA Ratio	3.54	6.04	0.56	0.13	1.61	2.09
Debt / FCF Ratio	3.67	9.23	0.07	0.13	0.73	4.63
Net Debt / Equity Ratio	-0.33	-0.28	-0.30	-0.23	-0.21	-0.02
Net Debt / EBITDA Ratio	-2.56	-3.77	-19.72	-3.54	-2.27	-0.11
Net Debt / FCF Ratio	-2.66	-5.77	-2.62	-3.56	-1.03	-0.24
Asset Turnover	0.18	0.21	0.19	0.17	0.19	0.18
Inventory Turnover	1.16	1.25	0.58	0.56	2.60	2.31
Quick Ratio	20.48	21.18	7.94	12.11	2.45	10.24
Current Ratio	21.28	22.23	8.93	14.15	2.67	11.15
Return on Equity (ROE)	23.21%	13.47%	-0.53%	8.29%	-0.74%	9.98%
Return on Assets (ROA)	7.06%	3.95%	-4.89%	1.45%	0.63%	7.20%
Return on Invested Capital (ROIC)	14.49%	6.84%	-6.74%	1.91%	0.86%	10.25%
Return on Capital Employed (ROCE)	6.28%	3.38%	-2.70%	1.37%	0.32%	8.25%
Earnings Yield	3.03%	3.24%	-	4.12%	-	2.14%
FCF Yield	2.42%	1.31%	4.65%	3.67%	10.59%	2.70%
Buyback Yield / Dilution	-9.71%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%
Total Shareholder Return	-9.71%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%

SEC Filings: 10-K · 10-Q